# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055729
Filing Date
2021-11-09
Accepted
2021-11-09 16:12:54
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | achv-10q_20210930.htm iXBRL | 10-Q | 2325902
2 | EX-31.1 | achv-ex311_6.htm | EX-31.1 | 9068
3 | EX-32.1 | achv-ex321_7.htm | EX-32.1 | 4891
| Complete submission text file | 0001564590-21-055729.txt |  | 7458986

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | achv-20210930.xsd | EX-101.SCH | 54087
5 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | achv-20210930_cal.xml | EX-101.CAL | 36772
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | achv-20210930_def.xml | EX-101.DEF | 210441
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | achv-20210930_lab.xml | EX-101.LAB | 391660
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | achv-20210930_pre.xml | EX-101.PRE | 304447
9 | EXTRACTED XBRL INSTANCE DOCUMENT | achv-10q_20210930_htm.xml | XML | 1232104

Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 211392290
SIC: 2835 In Vitro & In Vivo Diagnostic Substances